Deep-B3

Deep-B3 predicts blood-brain barrier (BBB) permeability of candidate compounds using a deep learning-based multi-model framework to support CNS drug development.

Key Features:

• Multi-Modal Feature Encoding: Encodes compounds using molecular descriptors, fingerprints (tabular), molecular graphs (graphical), and SMILES notation (textual).
• Pre-trained Feature Extractors: Employs pre-trained models to extract latent features from molecular graphs and SMILES and to transform these into formats suitable for deep learning (e.g., image and text data).
• Multi-Model Deep Learning Integration: Integrates multiple deep learning models to combine heterogeneous representations for prediction.
• Predictive Modeling of BBB Permeability: Uses deep learning to predict compound ability to penetrate the blood-brain barrier.
• Performance Validation: Demonstrated superior performance on an independent dataset compared to existing state-of-the-art models.

Scientific Applications:

• CNS Drug Development: Prioritizes candidate compounds based on predicted BBB permeability to inform therapeutic candidate selection for central nervous system disorders.
• Early-Stage Screening: Enables high-throughput in silico screening to identify promising BBB-permeable compounds before experimental testing.
• Lead Optimization: Supports structure–property analyses by linking molecular representations to predicted BBB penetration for medicinal chemistry decisions.

Methodology:

Compounds are encoded as molecular descriptors, fingerprints, graphs, and SMILES; pre-trained models extract latent features from graphs and SMILES (converted to image/text formats); these features are processed by integrated deep learning models to predict BBB permeability.